Khuong Chau Quang

CIK 00016094059 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001609405

Recent Transactions

50 trades

Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2023-06-22+14,250→ 14,250 total
Award
Galecto, Inc.$GLTO
Stock Option (right to buy)
2023-06-14+18,000→ 18,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 total
Award
Fusion Pharmaceuticals Inc.
Common Stock
2022-11-11$2.38/sh+42,093→ 42,093 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2022-06-23+14,250→ 14,250 total
Award
Galecto, Inc.$GLTO
/s/ Jonathan Freve, attorney-in-fact
2022-06-14+18,000→ 18,000 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2022-06-14+17,000→ 17,000 total
Award
Galecto, Inc.$GLTO
Stock Option (right to buy)
2021-11-17+9,000→ 9,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2021-06-24+14,250→ 14,250 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2021-06-04+17,000→ 17,000 total
Award
Galecto, Inc.$GLTO
Stock Option (right to buy)
2021-05-26+18,000→ 18,000 total
Award
SYNLOGIC, INC.$SYBX
Common Stock, $0.001 par value
2021-04-20$3.00/sh+1,666,666→ 3,696,662 total
Conversion
Galecto, Inc.$GLTO
Series C-5 Preferred Stock
2020-11-02−77,866→ 0 total
Conversion
Galecto, Inc.$GLTO
Series C-2 Preferred Stock
2020-11-02−116,800→ 0 total
Conversion
Galecto, Inc.$GLTO
Series C-2 Preferred Stock
2020-11-02−291,999→ 0 total
Conversion
Galecto, Inc.$GLTO
Series C-4 Preferred Stock
2020-11-02−272,533→ 0 total
Conversion
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-11-02−59,350→ 0 total
Purchase
Galecto, Inc.$GLTO
Common Shares
2020-11-02$15.00/sh+523,833→ 2,579,657 total
Purchase
Galecto, Inc.$GLTO
Common Shares
2020-11-02$15.00/sh+209,500→ 1,031,811 total
Conversion
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-11-02−148,395→ 0 total
Conversion
Galecto, Inc.$GLTO
Common Shares
2020-11-02+822,311→ 822,311 total
Conversion
Galecto, Inc.$GLTO
Series C-5 Preferred Stock
2020-11-02−31,147→ 0 total
Conversion
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-11-02−73,773→ 0 total
Conversion
Galecto, Inc.$GLTO
Common Shares
2020-11-02+2,055,824→ 2,055,824 total
Conversion
Galecto, Inc.$GLTO
Common Shares
2020-11-02+191,787→ 191,787 total
Conversion
Galecto, Inc.$GLTO
Series C-4 Preferred Stock
2020-11-02−109,013→ 0 total
Award
Inspire Medical Systems, Inc.$INSP
Common Stock
2020-10-09$130.00/sh+91→ 1,875 total
Award
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-09-25$27.11/sh−148,395→ 148,395 total
Award
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-09-25$27.11/sh−73,773→ 73,773 total
Award
Galecto, Inc.$GLTO
Series D Preferred Stock
2020-09-25$27.11/sh−59,350→ 59,350 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-18$108.54/sh−43,543→ 0 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-17$107.49/sh−94,900→ 43,543 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-14$109.03/sh−20,237→ 138,443 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-13$109.93/sh−29,251→ 158,500 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-12$107.45/sh−42,679→ 187,751 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-11$105.78/sh−39,877→ 230,430 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-10$105.23/sh−47,700→ 270,307 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-08-07$106.18/sh−28,993→ 318,007 total
Award
Inspire Medical Systems, Inc.$INSP
Common Stock
2020-07-10+128→ 1,784 total
Conversion
Fusion Pharmaceuticals Inc.
Common Shares
2020-06-30+2,224,770→ 2,224,770 total
Purchase
Fusion Pharmaceuticals Inc.
Common Shares
2020-06-30$17.00/sh+192,100→ 192,100 total
Conversion
Fusion Pharmaceuticals Inc.
Class B Preferred Shares
2020-06-30−11,878,051→ 0 total
Purchase
Fusion Pharmaceuticals Inc.
Common Shares
2020-06-30$17.00/sh+705,900→ 2,930,670 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2020-06-25+30,000→ 30,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2020-06-11+14,250→ 14,250 total
Award
SYNLOGIC, INC.$SYBX
Stock Option (right to buy)
2020-06-04+15,000→ 15,000 total
Purchase
Fusion Pharmaceuticals Inc.
Class B Preferred Shares
2020-06-02$1.15/sh+5,939,025→ 11,878,051 total
Award
Inspire Medical Systems, Inc.$INSP
Stock Option (right to buy)
2020-04-30+3,501→ 3,501 total
Award
Inspire Medical Systems, Inc.$INSP
Common Stock
2020-04-10+183→ 1,656 total
Sale
Inspire Medical Systems, Inc.$INSP
Common Stock, $0.001 par value
2020-03-06$83.52/sh−500,000→ 347,000 total

Companies

Recent Filings

Address

C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR

BOSTON, MA, 02109

View on SEC.gov